These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 18358632)

  • 21. The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance.
    Lykkegaard K; Larsen PJ; Vrang N; Bock C; Bock T; Knudsen LB
    Schizophr Res; 2008 Aug; 103(1-3):94-103. PubMed ID: 18579346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats.
    Kalinichev M; Rourke C; Daniels AJ; Grizzle MK; Britt CS; Ignar DM; Jones DN
    Psychopharmacology (Berl); 2005 Oct; 182(2):220-31. PubMed ID: 16001110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain.
    Weston-Green K; Huang XF; Deng C
    PLoS One; 2012; 7(3):e33548. PubMed ID: 22438946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Betahistine decreases olanzapine-induced weight gain and somnolence in humans.
    Barak N; Beck Y; Albeck JH
    J Psychopharmacol; 2016 Mar; 30(3):237-41. PubMed ID: 26839321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S; Ameen S; Akhtar S
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ziprasidone and aripiprazole attenuate olanzapine-induced hyperphagia in rats.
    Snigdha S; Thumbi C; Reynolds GP; Neill JC
    J Psychopharmacol; 2008 Jul; 22(5):567-71. PubMed ID: 18208914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crosstalk of hypothalamic chemerin, histamine, and AMPK in diet-and olanzapine-induced obesity in rats.
    Samy DM; Mostafa DK; Abdelmonsif DA; Ismail CA; Hassaan PS
    Life Sci; 2021 Nov; 284():119897. PubMed ID: 34450172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of thermogenesis in antipsychotic drug-induced weight gain.
    Stefanidis A; Verty AN; Allen AM; Owens NC; Cowley MA; Oldfield BJ
    Obesity (Silver Spring); 2009 Jan; 17(1):16-24. PubMed ID: 19107124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An animal model of antipsychotic-induced weight gain.
    Arjona AA; Zhang SX; Adamson B; Wurtman RJ
    Behav Brain Res; 2004 Jun; 152(1):121-7. PubMed ID: 15135975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of atypical antipsychotic drugs on body weight and food intake in dopamine D2 receptor knockout mice.
    Yoon S; Noh JS; Choi SY; Baik JH
    Biochem Biophys Res Commun; 2010 Mar; 393(2):235-41. PubMed ID: 20117094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen replacement reverses olanzapine-induced weight gain and hepatic insulin resistance in ovariectomized diabetic rats.
    Park S; Hong SM; Ahn IL; Kim DS; Kim SH
    Neuropsychobiology; 2010; 61(3):148-61. PubMed ID: 20173353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of antipsychotics on the density of cannabinoid receptors in the dorsal vagal complex of rats: implications for olanzapine-induced weight gain.
    Weston-Green K; Huang XF; Han M; Deng C
    Int J Neuropsychopharmacol; 2008 Sep; 11(6):827-35. PubMed ID: 18257959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine.
    Davoodi N; Kalinichev M; Korneev SA; Clifton PG
    Psychopharmacology (Berl); 2009 May; 203(4):693-702. PubMed ID: 19052729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histaminergic H1 and H2 receptors located within the ventromedial hypothalamus regulate food and water intake in rats.
    Magrani J; de Castro e Silva E; Varjão B; Duarte G; Ramos AC; Athanazio R; Barbetta M; Luz P; Fregoneze JB
    Pharmacol Biochem Behav; 2004 Sep; 79(1):189-98. PubMed ID: 15388299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of olanzapine-induced weight gain by the retinoid analog AM-80.
    Richards M; Chiba S; Ninomiya M; Wakabayasi C; Kunugi H
    Pharmacopsychiatry; 2013 Nov; 46(7):267-73. PubMed ID: 24105080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different effects of bifeprunox, aripiprazole, and haloperidol on body weight gain, food and water intake, and locomotor activity in rats.
    De Santis M; Pan B; Lian J; Huang XF; Deng C
    Pharmacol Biochem Behav; 2014 Sep; 124():167-73. PubMed ID: 24933333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.
    Kinon BJ; Basson BR; Gilmore JA; Tollefson GD
    J Clin Psychiatry; 2001 Feb; 62(2):92-100. PubMed ID: 11247108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats.
    Skrede S; Fernø J; Vázquez MJ; Fjær S; Pavlin T; Lunder N; Vidal-Puig A; Diéguez C; Berge RK; López M; Steen VM
    Int J Neuropsychopharmacol; 2012 Mar; 15(2):163-79. PubMed ID: 21854679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats.
    Raskind MA; Burke BL; Crites NJ; Tapp AM; Rasmussen DD
    Neuropsychopharmacology; 2007 Feb; 32(2):284-8. PubMed ID: 16710316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment.
    Minet-Ringuet J; Even PC; Valet P; Carpéné C; Visentin V; Prévot D; Daviaud D; Quignard-Boulange A; Tomé D; de Beaurepaire R
    Mol Psychiatry; 2007 Jun; 12(6):562-71. PubMed ID: 17211438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.